Insiders ORIC Pharmaceuticals, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 09:51:37 2024-05-17 am EDT			5-day change	1st Jan Change
8.985 ^USD	-0.39%		-3.00%	-5.22%

May. 06	ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 15	ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer	MT

Oric Pharmaceuticals Insider Sold Shares Worth $648,380, According to a Recent SEC Filing	Mar. 08	MT
Oric Pharmaceuticals Insider Sold Shares Worth $489,346, According to a Recent SEC Filing	Feb. 09	MT
Investor Caution Ahead of GDP Data, Jobless Claims Subdues Exchange-Traded Funds, Equity Futures Premarket	22-12-22	MT
Insider Buy: Oric Pharmaceuticals	22-05-16	MT
Insider Buy: Oric Pharmaceuticals	22-03-28	MT
ORIC Pharmaceuticals, Inc. Announces Directorate Changes	21-11-10	CI
Insider Sell: Oric Pharmaceuticals	21-09-14	MT
Insider Sell: Oric Pharmaceuticals	21-09-09	MT
ORIC Pharmaceuticals, Inc. Announces Board Changes	21-08-16	CI
ORIC Pharmaceuticals Appoints Lori Kunkel to Its Board of Directors	20-06-09	CI
ORIC Pharmaceuticals, Inc. Appoints Christian V. Kuhlen as General Counsel	20-04-02	CI
ORIC Pharmaceuticals Appoints Mardi C. Dier to Its Board of Directors	20-03-02	CI
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer	19-09-10	CI
ORIC Pharmaceuticals, Inc. Appoints Lori Friedman as Chief Scientific Officer	19-07-09	CI
ORIC Pharmaceuticals Names Edna Chow Maneval as Senior Vice President of Clinical Development	19-03-04	CI
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer	18-11-26	CI
ORIC Pharmaceuticals Appoints Pratik Multani as Chief Medical Officer	18-09-17	CI
ORIC Pharmaceuticals Announces Management Changes	18-05-07	CI
ORIC Pharmaceuticals, Inc. Announces Executive Changes	17-12-20	CI
ORIC Pharmaceuticals Announces Management Appointments	16-08-10	CI

No results for this search